Articles From: epay Adds McAfee Security Products to Its Software Portfolio to EPIX to Launch Premium TV App on Google Chromecast


LEAWOOD, Kan., Nov.
Sign-up for epay Adds McAfee Security Products to Its Software Portfolio investment picks
2014/9/25
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1147222&ProfileId=051205&sourceType=1 CHICAGO, IL --
Sign-up for Epazz Files First-Quarter 10-Q: Reports 21 Percent Increase in Revenues for First Quarter of 2014; Second-Quarter 10-Q in Process of Being Finalized investment picks
2014/10/2
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1148861&ProfileId=051205&sourceType=1 CHICAGO, IL --
Sign-up for Epazz Files Second-Quarter 10-Q: Reports 17 Percent Increase in Revenues for Second Quarter of 2014; Epazz Is Now Current investment picks
2014/10/3
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1149123&ProfileId=051205&sourceType=1 CHICAGO, IL --
Sign-up for Epazz Has Completed Acquisition of Cynergy; Epazz Expects to Add 15% to Recurring Revenue Stream investment picks
2014/9/26
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1147457&ProfileId=051205&sourceType=1 CHICAGO, IL --
Sign-up for Epazz Signed Purchase Agreement to Acquire Surveillance Software Company; Epazz Expects to Add Over $300,000 to Revenue Stream investment picks
Yovo takes ephemerality beyond just photo sharing with enhanced privacy tools that scramble screenshots and enable sharing across Facebook, Twitter, text and e-mail PLANO, Texas , Oct.
Sign-up for Ephemeral Photos And Messages Get More Private, Interactive And Fun With Yovo From ContentGuard investment picks
2014/11/17
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G026579-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/11/17/11G026579/EPIC_Corporation-949224062297.jpg AUSTIN, TX--(Marketwired - November 17, 2014) - EPIC Corporation Inc. (PINKSHEETS: EPOR) announces EPIC has acquired an exclusive worldwide license to all the rights to the EPIC Fabric Healthcare Products in exchange for all its ownership rights to the AcuFAB® trade name and design patent which was valued at $1.95 Million and receives a $1 Million License Fee from EPIC Medicor Corporation for Marketing & Distribution rights of EPIC Fabric Healthcare Products.
Sign-up for EPIC Acquires Exclusive Worldwide License to Healthcare Products Valued at $1.95M investment picks
http://media.marketwire.com/attachments/201401/215376_Logo1.jpeg http://media.marketwire.com/attachments/201410/80494_vlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1151397&ProfileId=051205&sourceType=1 BRIGNAIS, FRANCE and WOODBURY, NY --
Sign-up for Epic Aircraft E1000 Mockup Features Vision Systems SPD-Smart Nuance Electronically Dimmable Windows investment picks
2014/11/24
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G027110-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/11/24/11G027110/EPIC_Corporation-949224062297.jpg AUSTIN, TX--(Marketwired - November 24, 2014) - EPIC Corporation Inc. (PINKSHEETS: EPOR) and Ronald Tucker it CEO introduced "EPIC's AcuFAB ® Acupressure Insoles are made with a design patented medical textile AcuFAB ®. The design and architecture of the AcuFAB ® acupressure fabric is a unique spacer fabric and as a spacer fabric it provides technological solutions to medical conditions.
Sign-up for EPIC Creates New Revenue Source Introducing AcuFAB(R) Acupressure Insoles at Prices Anyone Can Afford investment picks
2014/11/12
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G026011-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/11/10/11G026011/EPIC_Corporation-949224062297.jpg AUSTIN, TX--(Marketwired - November 12, 2014) - EPIC Corporation (PINKSHEETS: EPOR) announces negotiations for supply of footwear insoles with major sport shoe manufacturers using the patented Epic Fabric Technology.
Sign-up for EPIC in Negotiations for Supply of Footwear Insoles Using Company's Patented Fabric Technology to Major Sport Shoe Manufacturers in $25 Billion Industry investment picks
2014/10/29
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G024894-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/10/29/11G024894/EPIC_Corporation-949224062297.jpg AUSTIN, TX--(Marketwired - October 29, 2014) - EPIC Corporation (PINKSHEETS: EPOR) ("EPIC") and Ronald S.
Sign-up for EPIC Proclaims Its Stock Is Undervalued and It Is Not a 'Shell Company' investment picks
2014/11/19
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G026799-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/11/19/11G026799/EPIC_Corporation-949224062297.jpg AUSTIN, TX --(Marketwired - November 19, 2014) - EPIC Corporation Inc. (PINKSHEETS: EPOR) announces the company has received a one time license fee of $1 Million from EPIC's Medicor Corporation for Marketing & Distribution rights of EPIC Fabric Healthcare Products in North America for medical market segments.
Sign-up for EPIC Receives $1M License Fee From Healthcare Products Company investment picks
2014/10/27
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G024643-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/10/27/11G024643/EPIC_Corporation-949224062297.jpg AUSTIN, TX--(Marketwired - October 27, 2014) - EPIC Corporation (PINKSHEETS: EPOR) ("EPIC") and Ronald S.
Sign-up for EPIC States Conviction That It Has Substantial Intrinsic Value and EPIC's Common Stock Is Significantly Undervalued investment picks
Survey Findings Reveal Incidence of First-Time Reactions in School Setting PITTSBURGH , Oct.
Sign-up for EpiPen4Schools® Program Enhances Support of National Movement to Improve Anaphylaxis Preparedness and Access to Emergency Treatment in Schools investment picks
2014/9/18
By Ben Eisen, MarketWatch NEW YORK (MarketWatch) -- Shares of EPIQ Systems surged Thursday after an activist investor said it took a stake in the company.
Sign-up for EPIQ surges on activist stake; Rite Aid sinks investment picks
KANSAS CITY, Kan., Sept.
Sign-up for Epiq Systems Issues Statement Regarding Recent Schedule 13D Filings investment picks
KANSAS CITY, Kan., Oct.
Sign-up for Epiq Systems Retains Credit Suisse to Assist Board in Review of Strategic Alternatives investment picks
2014/9/25
EPIRUS Biopharmaceuticals, Inc. (EPIRUS, NASDAQ: EPRS ), a Boston-based biopharmaceutical company focused on the global development and commercialization of biosimilar monoclonal antibodies, announced today that it has signed a royalty-bearing, multi-product collaboration agreement with Livzon Mabpharm Inc. (Livzon), a Chinese biotechnology company focused on the development, manufacture, and sale of antibody-based drugs.
Sign-up for EPIRUS and Livzon Mabpharm, Inc. Enter Collaboration Agreement for China investment picks
2014/9/23
EPIRUS Biopharmaceuticals, Inc. (EPIRUS, NASDAQ: EPRS ), a Boston-based biopharmaceutical company focused on the global development and commercialization of biosimilar monoclonal antibodies, today announced positive 58 week follow up data from its BOW015 efficacy and safety trial comparing BOW015, a biosimilar infliximab, to Remicade.
Sign-up for EPIRUS Announces Positive 58 Week Follow up Data for BOW015 for Treatment of Rheumatoid Arthritis investment picks
2014/12/2
EPIRUS Biopharmaceuticals, Inc. (EPIRUS, NASDAQ: EPRS ), a Boston-based biopharmaceutical company focused on the global development and commercialization of biosimilar monoclonal antibodies, today announced the launch of its first product, Infimab (BOW015), the first infliximab biosimilar in India.
Sign-up for EPIRUS Biopharmaceuticals Remicade® Biosimilar, Infimab™, Launches in India investment picks
2014/11/10
EPIRUS Biopharmaceuticals, Inc. (EPIRUS, NASDAQ: EPRS ), a Boston-based biopharmaceutical company focused on the global development and commercialization of biosimilar monoclonal antibodies, today provided a corporate update and reported financial results for the third quarter ended September 30, 2014.
Sign-up for EPIRUS Biopharmaceuticals Reports Third Quarter Results and Provides Corporate Update investment picks
2014/9/22
EPIRUS Biopharmaceuticals, Inc. (EPIRUS, NASDAQ: EPRS ), a Boston-based biopharmaceutical company focused on the global development and commercialization of biosimilar monoclonal antibodies, today announced that the company will present at the NewsMakers in the Biotech Industry conference at 2:30 PM EDT, Friday, September 26, at the Millennium Broadway Hotel in New York City.
Sign-up for EPIRUS to Present at NewsMakers in the Biotech Industry Conference investment picks
Veeco Instruments Inc. (Nasdaq:VECO) announced today that Epistar Corporation (TSE:2448) has successfully evaluated and accepted the new TurboDisc® EPIK700™ Gallium Nitride (GaN) Metal Organic Chemical Vapor Deposition (MOCVD) system for the production of light emitting diodes (LEDs). “As the leader in LED technology and commercialization, it is vital that we continue to push our roadmap to reduce solid state lighting costs with the most innovative and efficient production solutions available,” said Dr.
Sign-up for Epistar Qualifies Veeco’s New EPIK700 MOCVD System for High Volume LED Production investment picks
2014/9/16
Premium entertainment network EPIX announced today that Golden Globe and Emmy Award winner Jane Lynch (“Glee”) will lend her voice to the EPIX Original Documentary, To Russia With Love , that will make its World Premiere Wednesday, October 29 at 8PM ET .
Sign-up for EPIX Original Documentary To Russia with Love Explores LGBT Human Rights Journey as Seen Through Athletes’ Experience -- Premieres October 29 at 8PM ET investment picks
2014/10/22
Premium entertainment network EPIX will provide basketball fans courtside seats to Dwight Howard In the Moment , an EPIX Original Documentary that follows Dwight’s path from a small-town kid becoming a seven-time NBA All-Star and three-time NBA Defensive Player of the Year, to his fall from grace and road to redemption.
Sign-up for EPIX Presents Dwight Howard: In The Moment investment picks
2014/9/23
Premium TV network EPIX and the National Hockey League (NHL®) announced today that they have formed a partnership to produce and distribute a two-part original series, debuting on EPIX in December 2014, that will bring hockey fans onto the ice and behind-the-scenes with the Chicago Blackhawks and Washington Capitals as they prepare to compete in the 2015 Bridgestone NHL Winter Classic®, and the Los Angeles Kings and San Jose Sharks on their road to the 2015 Coors Light NHL Stadium Series™. Produced by 52-time Emmy award winner Ross Greenburg , the series will offer viewers an exclusive look inside the world of the NHL, with strategically placed cameras and microphones providing an all-access pass to players’ homes, locker rooms, training rooms, and the arena.
Sign-up for EPIX Teams with National Hockey League for Two-Part Series, Debuting in December 2014 investment picks
2014/11/19
EPIX Presents Road To The NHL Winter Classic™ and EPIX Presents Road To The NHL Stadium Series™ , a two-part original series from premium TV network EPIX and the National Hockey League, will bring U.S. viewers onto the ice and behind-the-scenes with the Chicago Blackhawks and Washington Capitals as they prepare to compete in the 2015 Bridgestone NHL Winter Classic®, and the Los Angeles Kings and San Jose Sharks on their road to the 2015 Coors Light NHL Stadium Series™. EPIX Presents Road To The NHL Winter Classic will make its U.S. Television Premiere on EPIX December 16 at 10pm ET/PT, 9CT with four weekly episodes following the Blackhawks and the Capitals through regular season games as they get ready to face off in the 2015 Bridgestone NHL Winter Classic® outdoor game at Nationals Park in Washington, D.C. on New Year’s Day, January 1.
Sign-up for EPIX Teams with National Hockey League for Two-Part, Eight-Episode Series, EPIX Presents Road To The NHL Winter Classic & EPIX Presents Road To The NHL Stadium Series investment picks
2014/11/25
Premium entertainment network EPIX announced that it is launching its EPIX app on Google Chromecast today, the latest step in its continued leadership in the expansion of TV Everywhere.
Sign-up for EPIX to Launch Premium TV App on Google Chromecast investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: epay Adds McAfee Security Products to Its Software Portfolio to EPIX to Launch Premium TV App on Google Chromecast
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent